http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114246990-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_52baa8a6cd7ea393081e3add161f2796
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01B33-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C01B33-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-02
filingDate 2021-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bcc552a3ded7b44c830a6f303d31e98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9dea9669a20a374c168f0f8e06729ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0652556891899d9fbde4c503dace613
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55990d327c4dda37bd7625787e05b593
publicationDate 2022-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-114246990-A
titleOfInvention A kind of preparation method of drug-loaded mesoporous calcium silicate modified PMMA bone cement, product and application thereof
abstract The invention relates to a preparation method of a drug-loaded mesoporous calcium silicate modified PMMA bone cement, its product and application, including the preparation of mesoporous calcium silicate, the preparation of drug-loaded mesoporous calcium silicate, and the gelatin coating treatment and modified PMMA bone cement preparation. The invention uses the drug-loaded mesoporous calcium silicate coated with gelatin as a drug carrier and a filler, which can promote the biocompatibility and osteogenic ability of the PMMA bone cement and reduce the elastic modulus of the bone cement; The dissolution rate in water, the cross-linking and fixation of biologically active drugs in mesopores, and under the protection of gelatin coating, can avoid the inactivation of polymerization and exothermic heat, which expands the clinical application scope of this type of bone cement.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115645620-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115317667-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023109377-A1
priorityDate 2021-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113694260-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014102539-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014294985-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010228358-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108286128-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012308633-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID944
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6517
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF6QDM7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83906
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCH0ZCS4
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP26617
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49151
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC0K3N4
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452927767
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC0K3N5
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57371080
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP16612
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7187
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ00731
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452554558
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15692
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449210251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449596929
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A3Q2TVI4
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559357
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555680
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ99PS1
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508668
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9GKR0
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15691
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9MYV3
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16211656
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP67860
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14941
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP50412
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2724691
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24414
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP67964
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP67965
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13521
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449950617
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555171

Total number of triples: 83.